Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder

NCT: NCT06457230 · RECRUITING

NCT IDNCT06457230
StatusRECRUITING
Start Date2024-12-24
Completion2026-09
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

Brief Summary

To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired cerebellar-medial prefrontal cortex (mPFC) pulses on methamphetamine use disorder patients and to develop a novel physiotherapeutic intervention to optimise the treatment and management.

Frequently Asked Questions

What is Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder?

Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder is a clinical trial registered under NCT06457230. Current status: RECRUITING.

What is the status of NCT06457230?

The current status of NCT06457230 (Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder) is: RECRUITING.

When did Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder start?

Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder started on 2024-12-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑